Screener
Allogene Therapeutics ALLO Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Commitments and Contingencies (Notes 6 and 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value: 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares were issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value: 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 244,816,413 and 229,413,523 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 245 | 229 |
| Additional paid-in capital | 2,332,129 | 2,302,753 |
| Accumulated deficit | (2,053,316) | (2,010,709) |
| Accumulated other comprehensive income (loss) | (183) | 269 |
| Total stockholders’ equity | 278,875 | 292,542 |
Item 1. Financial Statements - Unaudited
FAQ
- What is Allogene Therapeutics's common stock, par value (in dollars per share)?
- Allogene Therapeutics (ALLO) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Allogene Therapeutics's common stock, par value (in dollars per share) changed year-over-year?
- Allogene Therapeutics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Allogene Therapeutics's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Allogene Therapeutics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Allogene Therapeutics's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude